Treace Medical Concepts, Inc. Long-term Line of Credit, Noncurrent
Treace Medical Concepts, Inc. (TMCI) had Long-term Line of Credit, Noncurrent of $0 as of 2021-03-31, per its 10-Q filed 2021-05-25.
Discontinued › Balance Sheet › Liabilities › Liabilities, Noncurrent
us-gaap:LongTermLineOfCredit · last filed 2021-05-25
- 2021-03-31: Long-term Line of Credit, Noncurrent $0.00.
- 2020-12-31: Long-term Line of Credit, Noncurrent $0.00.
| Period end | Long-term Line of Credit, Noncurrent |
|---|---|
| 2021-03-31 | $0.00 10-Q · filed 2021-05-25 |
| 2020-12-31 | $0.00 10-Q · filed 2021-05-25 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Mobia Medical, Inc. (MOBI) | United States | $0.293B | |
| TriSalus Life Sciences, Inc. (TLSI) | United States | $0.283B | -9.92 |
| Embecta Corp. (EMBC) | United States | $0.319B | 2.10 |
| Cytosorbents Corp (CTSO) | United States | $0.274B | -1.29 |
| ORASURE TECHNOLOGIES INC (OSUR) | United States | $0.272B | -6.26 |
| Anika Therapeutics, Inc. (ANIK) | United States | $0.272B | -51.71 |
| InfuSystem Holdings, Inc (INFU) | United States | $0.253B | 22.52 |
| UTAH MEDICAL PRODUCTS INC (UTMD) | United States | $0.238B | 20.93 |
| SHOULDER INNOVATIONS, INC. (SI) | United States | $0.355B | |
| Orchestra BioMed Holdings, Inc. (OBIO) | United States | $0.356B | -4.39 |